Facebook Twitter LinkedIn Google Plus RSS

Cordis completes acquisition of stent developer

By ,

Cordis Corp., a developer of interventional vascular technology, on Tuesday announced it completed its acquisition of Flexible Stenting Solutions Inc., which produces flexible stents.

Financial terms were not disclosed.

Cordis, in Bridgewater, said in an announcement the addition of Flexible Stenting’s technology would allow the company to address unmet patient needs.

More From This Industry

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy